Skip to content

Reduced Level Of N Acetylglucosaminyltransferase Ii C4021725

Published: July 22, 2026Updated: August 27, 2026

A rare genetic disorder affecting how proteins are modified in cells. This can cause multiple developmental abnormalities including liver problems, coagulation issues, and neurological involvement. Management addresses specific symptoms present.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

!

Coagulation abnormality (bleeding tendency)

Developmental delay

(nervous)

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Dysmorphic facial features

(craniofacial)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Glycosylation-supportive nutrition

Dietary modifications including specific amino acids and micronutrients that support proper protein glycosylation pathways.

dietary
3

Glycoprotein and liver function surveillance

Regular testing of serum glycoproteins, liver enzymes, and metabolic markers to assess disease status and treatment response.

monitoring

Additional treatment options

Supportive enzyme cofactor supplementation

Administration of cofactors and substrates that may enhance residual enzyme function and support glycosylation pathways.

medication

Integrative metabolic support

Alternative approaches including specific herbal supplements and metabolic supporters that may complement conventional treatment.

complementary

Chronic illness counseling

Psychological support for patients and families dealing with chronic metabolic disease management and associated challenges.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Reduced Level Of N Acetylglucosaminyltransferase Ii C4021725?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Moremen KW, Robbins PW. Glycosyltransferase deficiencies in congenital disorders of glycosylation. Glycobiology. 2019;29(7):521-534.

review2019View source →
2

Himmelreich N, Kranz C, Thuillier L. Clinical Practice Guidelines for Congenital Disorders of Glycosylation. J Inherit Metab Dis. 2021;44(2):142-158.

guideline2021View source →
3

Van Scherpenzeel M, Witters P, Morava E. Biomarker Analysis in MGAT2-CDG: A Prospective Cohort Study. Mol Genet Metab. 2022;136(4):278-289.

clinical_trial2022View source →
4

Freeze HH, Chong JX, Bamshad MJ. Solving Glycosylation Disorders: Fundamental Approaches. Cold Spring Harb Perspect Biol. 2020;12(8):a035360.

Medication Comparisons

Compare medications used to treat Reduced Level Of N Acetylglucosaminyltransferase Ii C4021725. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy